ATNM News and Press, Actinium Pharmaceuticals Inc. From 01/10/23

Summary Actinium Pharmaceuticals is delivering the goods on a deep pipeline of therapeutics. It has deepened its bench with experienced operators. The sell-off over the data delay is overdone. Shares have drifted down from a November high of $14.41 to $9.88, offering an interest...

Actinium Highlights Survival Data in Relapsed/Refractory AML Patients with Prior Venetoclax Treatment and/or with a TP53 Mutation from the Actimab-A CLAG-M Combination Trial Oral Presentation at ASH PR Newswire -  59% 1-year overall survival and 32% 2-year overall survival ...

Actinium Pharmaceuticals, Inc. Announces Research Collaboration with Columbia University to Study Actimab-A in AML Patients Following Transplant of Engineered Hematopoietic Stem Cells Gene Edited to be CD33 Negative PR Newswire - Collaboration builds on the groundbreaking resear...

Actinium Announces Positive 1-Year and 2-Year Overall Survival Data for Patients with Relapsed or Refractory AML in Phase 1 Actimab-A CLAG-M Combination Trial PR Newswire 53% 1-year Overall Survival and 32% 2-year Overall Survival are approximately double outcomes with...

Actinium Pharmaceuticals ( NYSE: ATNM ), a biotech focused on targeted radiotherapies, announced Wednesday that former Novartis executive ( NVS ) ( OTCPK:NVSEF ) Caroline Yarbrough would join the company to lead its efforts to commercialize blood cancer therapy Iomab...

Actinium Appoints Seasoned Leader Caroline Yarbrough as Chief Commercial Officer to Spearhead Iomab-B Commercialization PR Newswire -Caroline joins Actinium from Novartis where she served as Portfolio General Manager, US Oncology -Proven commercial leadership experienc...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/360b Getty Images (NYSE: GETY ) stock is rising higher on Monday despite a lack of news concerning the company today. Instead, it looks like speculative meme stock traders are behind t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Dmitry Demidovich/ShutterStock.com Perfect (NYSE: PERF ) stock is taking off on Monday as investors pump shares higher on their first day of trading . Perfect and Provident Acquisition only recently c...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Actinium Pharmaceuticals (NYSEMKT: ATNM ) stock is gaining on Monday after posting positive results from a Phase 3 clinical trial. The point of this clinical trial was to determine the e...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com Welcome back and get ready for another week of trading with the biggest pre-market stock movers for Monday! We’ve got clinical trial data, reverse stock splits, as well as...